Annovis Bio, Inc. (ANVS)
NYSE·Healthcare·Biotechnology
$1.27
+1.06%
Mkt Cap $48.50M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (3 analysts)
$25.67
Range $21.00 – $30.00
Implied Upside
+1915.9%
Consensus $25.67 vs current $1.27
NYSE·Healthcare·Biotechnology
$1.27
+1.06%
Mkt Cap $48.50M
Buy
3
Hold
0
Sell
0
Price Target (3 analysts)
$25.67
Range $21.00 – $30.00
+1915.9%
Consensus $25.67 vs current $1.27